ARCHIVES

House Measure Would Eliminate AHRQ, Rescind PCORI, Cut Outcomes Research, And Halt NIH’s Title 42 Hiring Program

This article is from The Cancer Letter archive.

Vol. 38 No. 29 | July 20, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

September 25, 2009

NCI Awards $59M Contract For Key Project To consolidate Phase III Trial Administration

October 29, 1999

Publications: The Cigarette Papers Available On the Web

September 27, 1996

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

November 14, 1980

I-ELCAP Leaders Named as Inventors on 27 Patents; Journals Probe Disclosures.

January 18, 2008

In Brief: William Roper To Head Health Research Center; Announcement Of New NIH director Is Imminent

July 2, 1993